Guest guest Posted December 28, 2010 Report Posted December 28, 2010 From the sponsor: " Arno is also developing AR-42 (formerly known as " HDAC-42 " ), an orally available, broad spectrum inhibitor of both histone and non-histone deacetylation proteins ( " pan-DAC " ), which may both be important in cancer progression. Histone deacetylase ( " HDAC " ) inhibitors are a growing class of compounds that target histone deactylase, a molecule involved in determining which genes are expressed in a particular cell. This class has two approved agents, vorinostat ( " SAHA, " or ZolinzaR by Merck) and romidepsin (IstodaxR, Celgene). In preclinical studies, AR-42 has shown increased potency compared to SAHA, activity against a broad spectrum of deacetylation targets, and unique mechanisms for killing tumor-forming cancer stem cells (Hassane, et al). Recently published preclinical research done in the lab of of Byrd, MD at the Ohio State University demonstrated the in vitro and in vivo efficacy of AR-42 against B-cell malignancites ? at tolerable doses, and these results also suggested that AR-42 has greater efficacy in vitro as well as in vivo compared to vorinostat (Lucas, et al). [NOTE: I don't see how you can say " at tolerable doses " ahead of clinical testing? - or that it will have greater efficacy - that is what you can find out ONLY by clinical testing - in humans.] This combination of activity and potency may provide for a toxicity and efficacy profile that differentiates AR-42 from other HDAC inhibitors in this emerging class of compounds. Arno is currently enrolling an investigator-initiated Phase I/IIa study with AR-42 in collaboration with The Ohio State University in adult patients with relapsed or refractory multiple myeloma (MM), chronic lymphocytic leukemia (CLL) or lymphoma Study details: Safety/dose-finding trial: http://bit.ly/eG1aW5 All the best, ~ Karl Patients Against Lymphoma Patients Helping Patients Non-profit | Independent | Evidence-based www.lymphomation.org | Current News: http://bit.ly/f2A0T How to Help: www.lymphomation.org/how-to-help.htm Quote
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.